Illuminating Lives & Transforming Health

Kineon began with a core mission to empower the largest number of people in the most impactful way, to take ownership of their health and quality of life. 

Our light therapy devices provide an effective alternative approach to pharmaceuticals – providing not a band-aid solution, but a genuine shift in how we approach pain relief.

With FDA clearance, 9,000+ units sold, and $3.5M+ in sales, we believe Kineon is quickly becoming one of the most effective solutions for chronic pain on the market.

The Chronic Pain Epidemic

Chronic pain is a debilitating condition that affects over 20% of adults in the United States, and severely impacts the lives of millions of people every day.

For too long, the answer to chronic pain has been temporary and costly solutions, such as pharmaceuticals, that simply mask the pain without addressing the root cause.

These solutions are not only ineffective but also carry harmful side effects, leaving people trapped in a cycle of pain long-term.

To date, there are now over 6,000 clinical studies showing the benefits of light therapy for a huge variety of conditions, including acute injuries (MCL, ACL, meniscus tear or sprain) as well as inflammatory conditions like osteoarthritis, rheumatoid arthritis, tendinitis, and gout (Source).

Laser therapy has also proven to be very effective post-surgery to speed up recovery (Source | Source).

Affordable At-Home Laser Therapy

Traditional laser therapy devices can cost upwards of $15,000, making them inaccessible to many (Source). Meanwhile, most home-use devices rely solely on LED technology, lacking the penetrating power required for effective tissue targeting. 

Alternatives to laser therapy devices typically include costly surgeries, reliance on pharmaceutical drugs, or outdated R.I.C.E methods. 

That's why Kineon developed MOVE+ Pro: the next-generation laser therapy device that tackles chronic pain head-on in as little as 5 minutes. 

Unlike costly clinical treatments or ineffective home-use devices, MOVE+ Pro bridges the accessibility gap by offering sub-$500 pricing, optimal dosing, and a simple user experience. MOVE+ Pro works by combining LEDs and lasers in a narrower emission field, penetrating deep into the body for optimal dosing. 

Our wearable device works in direct contact with the skin, ensuring consistent and effective treatment. With MOVE+ Pro, individuals can manage their pain and inflammation at home, and take control over their health and quality of life.

Bringing Light Therapy Home & Beyond

For decades, the potential of light therapy has been hindered by complex dosing and prohibitive costs. However, the correct dosing has required testing to optimize and the cost to produce laser devices has made it prohibitive for home use until the last 3 years. 

Our target market, the chronic pain market is expected to reach $142.5B by 2033 (Source). But thanks to recent advancements in VCSEL lasers, Kineon has created MOVE+, a battery-driven, wearable system that brings the power of light therapy into the comfort of your home. 

The market has responded with enthusiasm, as evidenced by our growth, delivering over 9,000 devices worldwide within just 9 months, increasing our monthly revenue to $400K. From September 2022 to May 2023, we saw our sales increase from $80K to $400K. As a consequence, our COGS experienced an increase from $13,452 to $63,784.

*The above testimonials may not be representative of the opinions or of the experiences of other users and is not a guarantee of future performance or success.

The MOVE+ has been endorsed by world-renowned athletes, medical professionals, and biohackers who are getting incredible results, and sharing their journey with millions of people all over the world.

We've partnered with athletes from 6 renowned professional sports leagues including the NFL, Soccer, CrossFit, NBA, MLB, and Rugby, earning support from elite athletes like Sara Sigmundsdottir and Brooke Wells (both Crossfit Games Athletes with 1.8M+ IG followers). 

*The above testimonials may not be representative of the opinions or of the experiences of other professional athletes and users and is not a guarantee of future performance or success.

With the medical community's overwhelming support, we've been able to launch a Medical Practitioner Reseller (MPR) program to better reach those who need our product the most.

Our operations have received FDA and FCC clearances, and we've continued to develop and scale our U.S. and ROW warehouses to streamline shipments. 

We've already designed and shipped multiple product upgrades since August 2022, and we're now preparing to launch our next cutting-edge product, the Gut+ later this year. This device can be a huge step forward in supporting common gut health-related issues, like IBS, Crohn's and Colitis.

Our next anticipated game-changer, the Brain+, is in the works, which aims to treat a range of common cognitive disorders like anxiety, depression, PTSD, Alzheimer's, and dementia.

*This is a rendering of GUT+ and BRAIN+. Images are computer-generated demo versions. The products are still currently under development and are not yet available on the market.

We aim to expand our reach from the medical community and professional sports leagues, to beyond, transforming lives, one MOVE+ at a time.

Join the MOVE+ment

MOVE+ Pro, is a portable solution designed to deliver clinical dosing with ease and precision, to improve the quality of life for those that need it most. 

With world-class laser therapy devices that offer an effective alternative to pharmaceuticals, Kineon is transforming the landscape of red light therapy. 

We believe our monthly revenue growth from $80,000 to $400,000 in 9 months speaks volumes about the demand for our innovative solutions. 

Supported by FDA clearance and a previous Indiegogo campaign that raised $1.35 million, Kineon is backed by a strong community of users. Glowing reviews and endorsements from professional athletes and leagues further underscore our credibility. 

By investing in Kineon, you're not only supporting our mission to develop revolutionary devices, but also investing in a world where pain relief is accessible and life-changing for everyone.

We're inviting you to be a part of this journey and share in the success of a product that is transforming the way we approach chronic pain.